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Abstract: The first binuclear Gd-complex of the 12-mem-
bered pyridine-based polyaminocarboxylate macrocyclic
ligand PCTA was synthesized by C  C connection of the
pyridine units through two different synthetic procedures.
A dimeric AAZTA-ligand was also synthesized with the aim
to compare the relaxometric results or the two ditopic Gd-
complexes. Thus, the 1H relaxometric study on
[Gd2PCTA2(H2O)4] and on [Gd2AAZTA2(H2O)4]
2  highlighted
the remarkable rigidity and compactness of the two
binuclear complexes, which results in molar relaxivities (per
Gd), at 1.5 T and 298 K of ca. 12–12.6 mM  1 s  1 with an
increase of ca. 80% at 1.5 T and 298 K (+70% at 310 K)
with respect to the corresponding mononuclear complexes.
A large fraction (~40%) of clinical magnetic resonance imaging
(MRI) examinations requires the use of exogenous contrast
agents (CAs) that allow remarkable improvements in clinical
diagnosis in terms of higher specificity, better tissue character-
ization, reduction of image artefacts and functional information.
Paramagnetic GdIII complexes were early recognized as the
candidates of choice for the design of MRI CAs because of their
favourable magnetic properties associated with the presence of
seven unpaired electrons and relatively long electronic relaxa-
tion times.[1,2] The CAs approved for clinical use are monohy-
drated (q =1), low molecular weight GdIII complexes capable of
shortening the proton longitudinal relaxation times (T1=1/R1)
of neighbouring H2O molecules, thus increasing their signal
intensity in T1-weighted (T1w) MR images. This ability to induce
relaxation is called relaxivity (r1,2) and measures the relaxation
rate enhancement of water proton nuclei normalized to a 1 mM
concentration of the paramagnetic ion. At the magnetic fields
used in clinical (1.5 and 3 T) and preclinical scanners (up to
9.4 T) the relaxivity is mainly controlled by three parameters:
the exchange rate (kex=1/τM) and the number (q) of water
molecules coordinated to the metal centre and the rotational
correlation time (τR).
[3] The increase of the hydration state q of
the metal ion can be obtained by reducing the number of
donor atoms of the chelating ligand, which, however, may
result in a decreased stability of the complex. This latter is
assessed by measuring the thermodynamic stability and kinetic
inertness toward dissociation/ transmetallation reactions of a
Gd-complex that aims for in vivo applications. However, certain
macrocyclic and mesocyclic bis-hydrated complexes such as
GdPCTA (PCTA=3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-
1(15),11,13-triene-3,6,9-triacetic acid, Scheme 1)[4] or GdAAZTA
(AAZTA=6-amino-6-methylperhydro-1,4-diazepinetetraacetic
acid, Scheme 1)[5] were found to be characterized by excellent
inertness in physiological conditions, even better than that of
some non-macrocyclic q=1 complexes. In particular, it has
been recently shown that among the q=2 Gd-complexes, those
that show the highest kinetic inertness are GdPCTA and the
bicyclic AAZTA derivative GdCyAAZTA, with half-lives (t1/2) at
pH 7.4 of 4.4×106 and 8×105 h, respectively.[6]
Although no q=2 GdIII-complexes have been approved so
far for clinical use, the interest in these bis-hydrated complexes
is shown by the recent development by the pharmaceutical
industry Guerbet of a novel functionalized tris-serinolamido
PCTA derivative (Gadopiclenol, Scheme 1)[7] that exploits the
excellent stability and kinetic inertness of GdPCTA-like com-
plexes. Gadopiclenol shows remarkable relaxivity values due to
its large molecular weight, the position of the Gd ion located
almost at the barycentre of the molecule and the presence of
hydrophilic polyalcohol pendants that favour the additional
contribution of second sphere water molecules (SS) to r1.
Although the molecule does not possess the high symmetry
typical of the GdDOTA-derivatives reported in early 2000,[8] the
combination of the SS water molecules contribution and of a
longer rotational correlation time provides high relaxivities over
a broad range of magnetic field strengths.
A further approach to increase the relaxivity of a Gd-
complex at clinically relevant magnetic fields (1.5–3 T) is the use
of multimeric GdIII-agents of medium molecular weight (1-
4 kDa), roughly corresponding to bi-, tri- or tetranuclear
complexes. These systems allow to attain high ionic relaxivities
(per Gd) which reach maximum values precisely in the range of
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approx. 1–5 T.[9] Therefore, oligomeric systems (e.g. 2–4 chelates
rigidly linked together) with τR values between ca. 150–500 ps
show relaxivity peaks at high proton Larmor frequencies
(>40 MHz).[9] Several oligomeric contrast agents have been
reported in the literature based on both q=1 (DOTA-like) and
q=2 (AAZTA-like) Gd-complexes. Remarkable results have been
obtained when the advantages of the slower rotational
dynamics are combined with fast water exchange rates and
second hydration sphere contributions.[10,11] Notably, no exam-
ples of multimeric systems based on PCTA ligand have been
reported in the literature. The synthesis of binuclear Gd-
complexes has also been recently pursued by another contrast
media company, that patented a series of ditopic GdHPDO3A-
like systems linked by polyaminoalcohol groups to increase the
SS contribution.[12] In this regard, it should be noted that the
linker between the paramagnetic units in an oligomeric agent
plays a key role for the attainment of high relaxivities. The linker
needs to be as rigid as possible to favour an optimal motional
coupling between the discrete interconnected chelates and,
possibly, hydrophilic to enable the formation of strong hydro-
gen bonds with SS water molecules.
In this contribution, we combined the two approaches by
synthesising a PCTA dimer in which the two units are directly
connected through the pyridine moieties (PCTA2, Scheme 1) to
minimize local rotational motions. The synthesis of such a
dimeric molecule is quite challenging and we followed two
different strategies. The first involves the Ni(0)-catalysed homo-
coupling of the bromopyridine-functionalized macrocycle,
whereas the second is based on the synthesis of the
tetrabromomethyl-bipyridine derivative (6 in Scheme 2) to be
used for bis-macrocyclization. For a comparison, a dimeric
GdAAZTA-complex was also synthesized by linking together
two AAZTA-OH moieties.[13] The Gd-complexes of these ditopic
ligands were then investigated in detail through 1H NMR
relaxometry to assess their structural and dynamic properties in
solution and their relaxation efficiency.
Design and synthesis
The design of a dimeric Gd-complex requires the rational choice
of the monomeric chelate and of the linker connecting the two
units. We have already discussed the choice of a stable q=2
Gd-complex, such as GdPCTA or GdAAZTA, to achieve a higher
inner sphere contribution to the relaxivity. In addition, it is
important to avoid the easy rotation around the linker because
this implies a poor correlation between the motions of the
single chelates and the global molecular reorientation.[14] A
poor motional coupling invariably results in decreased relaxiv-
ity. As noted above, a further important contribution to r1 arises
from the presence of H-bonded water molecules in the
proximity of the paramagnetic centres either by interaction
with the linker or with the hydrophilic moieties of the chelates.
Several examples of ditopic Gd-complexes have been designed
to obtain improved relaxivity enhancement with respect to the
monomeric units following these approaches.[15] Nonetheless,
the advantage of PCTA as compared to the other polyamino-
carboxylate ligands such as DOTA or AAZTA is related to the
presence of a pyridine unit within the bis-macrocyclic structure
that can be used to connect two ligands together. Thus, by
directly linking two pyridine moieties in position 4 through a
metal-catalysed homocoupling reaction a rigid and compact
dimeric system with a zero-length cross linker can be obtained.
In a structure of this type, the local motions of the single units
should be minimized relative to the global molecular tumbling
and therefore the increase in the molecular mass of the
binuclear complex should translate into a corresponding
increase in τR and therefore in relaxivity (per Gd).
In a first synthetic approach of PCTA2, the key step was the
Ni(0)-catalysed homocoupling reaction[16] between two units of
the N-tosyl-protected p-bromo-pyclen derivative (Scheme 2).
First of all, the diethyl ester of dipicolinic acid incorporating a
bromo group in the para position, was obtained from
chelidamic acid by bromination with PBr5 and esterification,
following the literature procedure.[17] Then, the cyclization
reaction was carried out using the procedure optimized for
PCTA,[18] i.e. reaction of 4-bromo-2,6-bis-bromomethylpyridine
Scheme 1. Ligands discussed in the text.
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and 1,4,7-tritosyl-1,4,7-triazaeptane in anhydrous acetonitrile in
the presence of potassium carbonate.
The homocoupling reaction was carried out in DMF in the
presence of NiCl2, triphenilphosphine and Zn dust obtaining the
ditopic ligand in good yield after column chromatography.
Hydrolysis of the tosylate groups was accomplished with HBr
33% in acetic acid followed by alkylation of the six secondary
amines with tert-butylbromoacetate. Deprotection of the tert-
butyl esters with a 1 :1 mixture of CH2Cl2 and trifluoroacetic acid
resulted in the final ligand PCTA2 in good yield.
In the literature there are no examples of the formation of
ditopic or multimeric macrocyclic ligands linked together
through homo- or cross-coupling reactions, although coupling
reactions are used for the synthesis of large macrocycles or of
porphyrin systems.[19] On the other hand, pyridine-based ditopic
chelators are reported in the literature, but their synthesis starts
from the formation of functionalized 4,4’-bipyridine. In one
case, 4,4’-bipyridine was acetylated in the 2,2’,6,6’ positions
using pyruvic acid, AgNO3 e ammonium persulfate;
[20] the
tetraacetylated bipyridine was then used to form a bis-pentaaza
macrocycle by Mn(II) template imine formation. In other
examples,[21] the 2,2’,6,6’-tetramethyl-4,4’bipyridine was synthe-
sized using Hunig’s method by reductive coupling of 2,6-
lutidine with Na in THF followed by oxidation with SO2.
[22]
In the second synthetic path, we followed the same
procedure to obtain the bis-PCTA macrocycle. Thus, the
tetramethyl derivative, obtained by Hunig’s approach,[22] was
oxidized with CrO3 and esterified passing through the tetraacyl
chloride derivative. Then, reduction of the esters followed by
treatment of the tetraol 5 with thionyl bromide produced the
tetrabromomethyl bipyridine 6 in good yield.[21]
In this case, the cyclization was carried out by using the
diethylentriamine-N,N’,N’’-triacetic acid in the presence of
Na2CO3 in acetonitrile at reflux following the method reported
by Picard and colleagues.[23] With this approach, the macro-
cyclization reaction is carried out in diluted conditions (concen-
tration 2×10  3 M) and controlled by a sodium template effect.
No sign of oligomerization or other by-product formation were
detected by HPLC-MS analysis. Finally, the tert-butyl ester
groups in the bis-macrocycle 4 were deprotected to obtain the
final dimeric ligand PCTA2 in reasonable yield.
To compare the data on the Gd-complex of PCTA2, another
fairly rigid q=2 dimeric AAZTA-based ligand was synthesized
by reaction of 1,4-phenylene diisocyanate with AAZTA-OH,[13]
followed by deprotection of the tert-butyl esters with a 1 :1
mixture of CH2Cl2 and trifluoroacetic acid (Scheme 3). In this
case, although the linker is much longer than that used for
PCTA2, it contains only two sp
3 carbon atoms and the aromatic
Scheme 2. Synthesis of PCTA2. i. K2CO3, CH3CN; ii. NiCl2, PPh3, Zn, DMF; iii. HBr 33% in AcOH; iv. BrAcOtBu, NEt3, N-methylpyrrolidone; v. NaBH4, CaCl2, EtOH; vi.
SOBr2; vii. diethylentriamine-N,N’,N’’-tris-tertbutyl acetate, Na2CO3, CH3CN; viii. TFA/DCM 1 :1.
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ring and the carbamate moieties should substantially hinder
the local flexibility of the monomeric units.
Complexation reactions were carried out at pH=6.5 by
mixing at room temperature two molar equivalents of GdCl3
with one equivalent of the dimeric ligand and the formation of
the complexes were supported by ESI MS analysis and HPLC
method (Supporting Information Figure S1–S5).
1H NMR relaxometric study
The ionic (per Gd) relaxivity (r1) values of the dimeric complexes
[Gd2PCTA2(H2O)4] and [Gd2AAZTA2(H2O)4]
2  , measured at pH 7,
20 MHz (0.47 T) and 298 K, are 12.1 and 12.6 mM  1 s   1,




  [25] show r1 values of 6.9 and 7.6 mM
  1 s  1, respectively,
measured under identical experimental conditions. Therefore,
the binuclear Gd-complexes exhibit a relaxivity gain of +76%
([Gd2PCTA2(H2O)4]) and +66% ([Gd2AAZTA2(H2O)4]
2  ), easily
attributed to a longer value of the rotational correlation time
associated with the increased molecular size, while the state of
hydration remains unchanged (q=2). Thus, since only the
inner-sphere contribution to relaxivity depends on τR, whereas
the outer-sphere contribution remains essentially unaffected,
we can infer that the binuclear complexes are remarkably rigid
and compact, hence their tumbling motion is largely isotropic
as expected, in both cases, by the nature of the linkers
connecting the two coordination cages.
The pH dependence of r1 was measured for both complexes
in the 4–11 pH range, at 20 MHz and 298 K as it provides useful
insights into their solution behaviour and stability. The data
reported in Figure 1A shows r1 values constant over the entire
pH range for [Gd2AAZTA2(H2O)4]
2  to indicate that the coordi-
nated water molecules are not displaced by CO3
2  anions, even
when present at relatively high concentration as in the basic pH
region. In the case of [Gd2PCTA2(H2O)4], r1 remains constant up
to ca. pH 8.5 where it begins to decrease until it reaches the
value of 8.5 mM  1 s  1 at pH 11.2 (  32%), likely as a result of a
partial water displacement by carbonate anions present in the
aerated solution. This behaviour is rather common for q >1 Gd-
complexes, such as GdDO3A or GdEDTA.[24]
The magnetic field dependence of the relaxivity, the so-
called NMRD (nuclear magnetic relaxation dispersion) profile,
has been measured at 25 and 37 °C (for [Gd2PCTA2(H2O)4] also at
10 °C) over the proton Larmor frequency range 0.01 to 500 MHz,
corresponding to magnetic field strengths varying between
2.34×10  4 T and 11.7 T (Figure 2). The temperature dependence
of r1 was also measured for both complexes at 20 MHz over the
range 274–340 K and is shown in Figure 1B. The shape of the
NMRD profiles and their temperature dependence (r1 decreases
with increasing temperature) reproduce the general behaviour
of low molecular weight Gd-complexes, for which r1 is not
limited by the water exchange rate (fast exchange regime) but
rather by the rotational motion, as for the related monomeric
complexes.
The NMRD profiles were fitted in terms of the established
theory of paramagnetic relaxation expressed by the Solomon-
Bloembergen-Morgan (SBM)[26] and Freed’s[27] equations for the
inner- (IS) and outer sphere (OS) proton relaxation mechanisms,
respectively. Some of the parameters (q, rGdH, a, D) were fixed to
known or reasonable values as indicated in Table 1. The
residence lifetime of the coordinated water molecules, τM, does
not affect the relaxivity of the systems under the regime of fast
exchange and their values were fixed to those reported for the
mononuclear GdPCTA and GdAAZTA complexes (70 and 90 ns,
Scheme 3. Synthesis of AAZTA2.
Figure 1. Plots of the 1H relaxivity for [Gd2PCTA2(H2O)4] (black squares) and
for [Gd2AAZTA2(H2O)4]
2  (red circles) as a function of pH (A, 20 MHz and
298 K) and temperature (B, 20 MHz, pH 7).
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respectively).[24,25] The fit was performed using as adjustable
parameters τR and the electronic relaxation parameters Δ
2 (trace
of the squared zero-field splitting, ZFS, tensor) and τV
(correlation time for the modulation of the transient ZFS). The
NMRD profiles are well reproduced with the set of parameters
reported in Table 1, which clearly show that the improved r1
values of the dimeric complexes and their frequency depend-
ence can be well accounted for by the longer τR values, i. e.
slower molecular tumbling. For the neutral dimer
[Gd2PCTA2(H2O)4], the τR value is more than double that
reported for GdPCTA, confirming the almost total absence of
local rotational motions superimposed on the global molecular
reorientation. This makes it possible to effectively translate the
increase in molecular mass into a corresponding increase in τR.
This is not entirely true for the other dimeric complex,
[Gd2AAZTA2(H2O)4]
2  , where the increments of the molecular
mass and τR are not entirely proportional. This suggests the
occurrence of some degree of internal mobility through the CH2
groups connecting the phenyl-bis-carbamate unit. Noteworthy,
the values reported in Table 1 are the ionic relaxivities (per
Gd3+). The molecular relaxivities correspond to double values
that, at 20 MHz and 298 K, are equivalent to ca. 24–25 mM  1 s  1.
It is also important to highlight that for these dimeric systems
the r1 values per Gd at the clinical fields of 1.5 and 3 T are
significantly higher than those of the mononuclear complexes
(at 310 K ca. 70% for [Gd2PCTA2(H2O)4] and 68% for
[Gd2AAZTA2(H2O)4]
2  ] (Figure 3).
It is worth noting that, unlike the binuclear complexes
herein reported, other binuclear GdDO3A-like complexes with
xylene group as spacers were reported to form large
supramolecular aggregates. The aggregates show high relaxiv-
ity values at low field (ca. 12 mM  1 s  1 at 20 MHz and 298 K),
which drop down at higher field (>1 T) due to τR values in the
order of 0.5–1 ns.[28]
In conclusion, we have reported the synthesis of the first
binuclear Gd-complex of the 12-membered pyridine-based
polyaminocarboxylate macrocyclic ligand PCTA by connecting
Figure 2. 1/T1
1H NMRD relaxivity data for [Gd2PCTA2(H2O)4] (top) and for
[Gd2AAZTA2(H2O)4]
2  (bottom) at pH=7.0: 283 K (blue squares); 298 K (black
circles); 310 K (red diamonds). The solid lines represent the best results of
the fitting to the experimental points (see Table 1).
Table 1. Parameters obtained from the simultaneous analysis of 1H NMRD profiles for [Gd2PCTA2(H2O)4] and for [Gd2AAZTA2(H2O)4]
2  compared to the
related monomeric complexes.





298/310 (mM  1 s  1) 12.0/8.8 6.9/5.2 12.5/8.6 7.1/5.2
Δ2 (1019 s  2) 2.6�0.2 5.9 3.1�0.1 2.2
τV
298 (ps) 30.7�0.7 15 29.5�0.9 31
kex
298 (106 s  1) 14.3 14.3 11.1 11.1
τR
298(ps) 163�2 70 145�1 74
r (Å) 3.1 3.1 3.1 3.1
[a] Ref. 24; [b] Ref. 25; * Values fixed in the fitting: the hydration number q; the distance between Gd3+ and the protons of the bound water molecule, r; the
distance of closest approach, a, of the outer sphere water molecules to Gd3+ was set to 4.0 Å and for the relative diffusion coefficient D standard value of
1.7, 2.24 and 3.1×10  5 cm2 s  1 (at 283, 298 and 310 K, respectively).
Figure 3. Plot of the ionic relaxivity values of [Gd2PCTA2(H2O)4] and
[Gd2AAZTA2(H2O)4]
2  at 0.5, 1.5 and 3.0 T and at 310 K compared to the
corresponding mononuclear complexes.
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two pyridine units via a simple C  C bond. This was achieved
through two distinct synthetic procedures: 1) by synthesizing
first the p-bromopyridine moiety already included in a
protected pyclen macrocycle, followed by the Ni(0) catalysed
homocoupling; 2) by synthesizing the 2,2’,6,6’-bromomethyl-
substituted bis-pyridine by a multistep procedure, followed by
the cyclization with a triaminotris-tButylcarboxylate moiety. A
dimeric AAZTA-ligand was also successfully synthesized with
the purpose of collecting relaxometric data in parallel for two
binuclear complexes of similar size but different molecular
structure and thus be able to make a useful comparison.
The 1H relaxometric study on [Gd2PCTA2(H2O)4] and for
[Gd2AAZTA2(H2O)4]
2  highlighted the remarkable rigidity and
compactness of the two binuclear complexes, which results in r1
increases of ca. 80% at 1.5 T and 298 K (+70% at 310 K). In
particular, [Gd2PCTA2(H2O)4] showed a rotational correlation
time more than doubled with respect to the monomeric
GdPCTA complex, as a consequence of the zero-length linker
between the two GdPCTA units. In the case of the binuclear
AAZTA-like complex the relaxometric performance are in line
with other dimeric AAZTA systems previously reported in the
literature.[15e, 29]
It is also interesting to note that these binuclear complexes
have a relaxivity about three times higher than commercial
contrast agents (q=1), allowing the injection of lower doses of
GdIII and thus mitigating potential toxicity problems.
These data further confirm that the design and synthesis of
binuclear Gd-complexes with high stereochemical rigidity
represents an effective and simple strategy to achieve remark-
able relaxivity enhancement at the magnetic field strengths
useful for clinical applications (1.5–3 ). In the case of GdAAZTA
systems, it has been highlighted that the kinetic inertness is
much higher than that of linear GdDTPA or GdDTPA-bisamide
complexes and can be highly improved by increasing the
stereochemical rigidity with the inclusion of a cyclohexyl ring in
the structure of the ligand.[6] On the other hand, being GdPCTA
the most inert q=2 Gd-complex so far reported in the
literature, a possible additional contribution from the presence
of a well-defined second hydration sphere may further increase
the relaxivity of this type of binuclear complex making it a valid
alternative to the Gd-based CAs applied in clinics.
Finally, we would like to emphasize that pyclen-diacetates
(PC2A) has been recently investigated as highly efficient ligands
for MnII-based MRI contrast agents.[30] Thus the dimerization
approach reported for Gd2PCTA2 can have further application
also in the field of MnII agents.
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